Pulmonary arterial hypertension (PAH) is a progressive condition with no cure. Scientists at Cedars-Sinai Medical Center are using donor cells derived from the heart to reduce two hallmark symptoms of pulmonary…
Research Objective The origins of brain vascular mural cells are unknown. This proposal will identify mural stem cells in the developing human and mouse brain and determine their impact on…
Research Objective To develop drugs to treat Calcific Aortic Valve Disease (CAVD), the third leading cause of adult heart disease, by screening a stem cell-based platform based on CAVD patient-derived…
Research Objective To assess the therapeutic effect of human induced pluripotent stem cell (iPSC)-derived smooth muscle progenitors (pSMCs) for treatment of abominal aortic aneurysm (AAA). Impact Currently, there are no…
Research Objective We aim to develop an angiogenic proteoglycan mimic that will protect tissue from rapid degradation, and in conjunction with EPCs promote angiogenesis in order to accelerate ischemic wound…
Robert Klein, J.D. and Claire Pomeroy, M.D., M.B.A., gave the welcoming remarks for the "Spotlight on Cardiovascular Therapies," an educational event presented at the California Institute for Regenerative Medicine Governing…
"Stem Cell Research: Where are we with Peripheral Arterial Disease (PAD)" On March 10, 2011, Yung-Wei Chi, D.O., spoke about a recently launched clinical trial that using a patient's own…
"Patient Advocate Speaker" On March 10, 2011, Jeanette Owens spoke about living with peripheral arterial disease and about her hopes for stem cell treatments. Owens was introduced by Claire Pomeroy,…
